




Searching News Database: Indivior
HSMN NewsFeed - 27 Jun 2019
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
DURECT Announces Submission to FDA of a Full Response to the POSIMIR(R) Complete Response Letter
HSMN NewsFeed - 22 Feb 2019
Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence
Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence
HSMN NewsFeed - 14 May 2018
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
HSMN NewsFeed - 23 Apr 2018
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
HSMN NewsFeed - 7 Oct 2016
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
HSMN NewsFeed - 6 Oct 2016
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)